Suchergebnisse - "Genovese, Mark C"

PubPharm (292)

1

A Randomized, Double-Blind, Sham-Controlled, Clinical Trial of Auricular Vagus Nerve Stimulation for the Treatment of Active Rheumatoid Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Baker, M. | Kavanagh, S. | Cohen, S. | +6

CommentIn: Arthritis Rheumatol. 2023 Dec;75(12):2103-2105. - PMID 37463120

2

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Baker, M. | Genovese, M. | Alataris, K.

3

A plain language summary of what clinical studies can tell us about the safety of evobrutinib - a potential treatment for multiple sclerosis

enthalten in: Neurodegenerative disease management | 2023

von Montalban, X. | Wallace, D. | Genovese, M. | +5

4

A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis

enthalten in: Rheumatology (Oxford, England) | 2023

von Baker, M. | Horomanski, A. | Wang, Y. | +7

5

Characterisation of the safety profile of evobrutinib in over 1000 patients from phase II clinical trials in multiple sclerosis, rheumatoid arthritis and systemic lupus erythematosus : an integrated safety analysis

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2023

von Montalban, X. | Wallace, D. | Genovese, M. | +5

6

Long-Term Safety, Efficacy, and Patient-Centered Outcomes of Filgotinib in the Treatment of Rheumatoid Arthritis : Current Perspectives

enthalten in: Patient preference and adherence | 2023

von Tanaka, Y. | Genovese, M. | Matsushima, H.

7

Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 years

enthalten in: Modern rheumatology | 2023

von Ishiguro, N. | Tanaka, Y. | Matsubara, T. | +17

8

The Incidence, Prevalence, and Associated Costs of Anemia, Malignancy, Venous Thromboembolism, Major Adverse Cardiovascular Events, and Infections in Rheumatoid Arthritis Patients by Treatment History in the United States

enthalten in: ACR open rheumatology | 2022

von Dore, R. | Antonova, J. | Burudpakdee, C. | +3

9

Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years

enthalten in: Annals of the rheumatic diseases | 2022

von Winthrop, K. | Tanaka, Y. | Takeuchi, T. | +10

10

Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis : Subgroup analyses of a global phase 3 study (FINCH 2)

enthalten in: Modern rheumatology | 2022

von Takeuchi, T. | Matsubara, T. | Atsumi, T. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]